Surface Pharmaceuticals

About:

Surface Pharmaceuticals is an owner and operator of a pharmaceutical company intended to provide ophthalmology products.

Website: http://surfacepharma.com/

Twitter/X: surfacepharma

Top Investors: Visionary Venture Fund, Flying L Partners

Description:

Surface Pharmaceuticals is an owner and operator of a pharmaceutical company intended to provide ophthalmology products. The company's medicines use topical formulations with the patented Klarity delivery vehicle, designed to protect and rehabilitate the ocular surface, enabling patients with dry eye disease to recover on time and properly.

Total Funding Amount:

$46.8M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

California City, California, United States

Founded Date:

2017-01-01

Founders:

Mark Baum

Number of Employees:

1-10

Last Funding Date:

2021-06-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai